ARCUS BIOSCIENCES INC (RCUS) Stock News

NYSE:RCUS - New York Stock Exchange, Inc. - US03969F1093 - Common Stock - Currency: USD

9.31 +0.16 (+1.75%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RCUS Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Arcus Biosciences

Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer

12 days ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

a month ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

3 months ago - By: Benzinga - Mentions: ENLT SSL ATKR GPOR ...

Earnings Scheduled For May 6, 2025

3 months ago - By: Benzinga

What to Expect from Arcus Biosciences's Earnings

a month ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

2 months ago - By: Arcus Biosciences

Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response

2 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

2 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

3 months ago - By: Zacks Investment Research - Mentions: PCRX

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Lags Revenue Estimates

3 months ago - By: Arcus Biosciences

Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update

3 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

3 months ago - By: Arcus Biosciences

Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting

3 months ago - By: Arcus Biosciences

Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update

3 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

4 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

5 months ago - By: Arcus Biosciences

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

5 months ago - By: Arcus Biosciences

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

5 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

5 months ago - By: Arcus Biosciences

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

5 months ago - By: Arcus Biosciences

Arcus Biosciences, Inc. Announces Underwritten Offering of Common Stock

5 months ago - By: Arcus Biosciences

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

5 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants

5 months ago - By: Arcus Biosciences

Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

6 months ago - By: Arcus Biosciences

Arcus Biosciences Announces New Employment Inducement Grants